Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Biseko vs Albumin in SIRS
NCT00708747Phase 4Completed
- Sponsor
- Medical University of Vienna
- Start
- Jul 1996
- Primary completion
- Jun 2001
- Modality
- Recombinant Proteins and Enzymes
- Countries
- 1
01
Overview
Phase 4, randomised trial of albumin + immunoglobulin in Systemic Inflammatory Response Syndrome (SIRS) (2 arms), sponsored by Medical University of Vienna. Primary endpoint: Serum Cytokine Levels (IL-1ß, IL-6, TNF-α, TNF-R). Started Jul 1996; status: completed.
02
Drugs
albumin + immunoglobulin
03
Conditions
Systemic Inflammatory Response Syndrome (SIRS)
Beyond the preview
Go deeper on NCT00708747.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT00708747.